ABBV vs PEPG

AbbVie Inc. (ABBV) is a well-established mega-cap pharmaceutical company with a robust product portfolio, strong financial health, and a leading position in key therapeutic areas. It excels as a stable dividend payer and a defensive holding. However, its fundamental characteristics, including its immense market capitalization ($397.29B), the mature nature of the pharmaceutical industry, high R&D c...

Score Change Explanation: The previous score of 80/100 (8/10) on 2026-02-13 was based on PepGen's robust EDO platform and lead candidate PGN-EDO51 for DMD, anticipating future market leadership. However, since the last analysis, material adverse events have significantly altered the investment thesis and risk profile. On March 4, 2026, the FDA placed a partial clinical hold on the FREEDOM2-DM1 Pha...